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Vibration white finger (VWF) is the episodic blanching
of the fingers that occurs in response to cold in those
who work with hand-held vibrating tools. Clinically the
condition differs from primary Raynaud’s phenomenon
as persistent pain and paresthesia are common in the
hands and arms and occur independently of the ‘‘white
attacks.’’ We have previously reported a decrease in
protein gene product 9.5 and calcitonin gene-related
peptide-immunoreactive nerve fibers in the digital skin
of individuals with VWF. In this study, we have sought
to determine whether this deficit of immunoreactive
sensory-motor nerves has a functional counterpart in vivo.
Histamine produces a rapid wheal and flare response
following intradermal injection, whereas endothelin-1
(ET-1) produces a central area of pallor with a sur-
rounding neurogenic flare. In contrast, calcitonin gene-
related peptide produces a non-neurogenic erythema. In
this study, histamine and ET-1 were injected into the
dorsum of the middle phalanx and the local neurovascular
response was assessed by measuring the area of the visible
flare or pallor. Basal finger blood flow was also measured
by laser Doppler flowmetry in each of the digits prior to
intradermal injection. The experiments were performed
at 21°C and 4°C. Patients with VWF and asymptomatic
It is now well recognized that the long-term use of hand-heldvibrating tools can result in episodic vasospasm and blanchingof the fingers. Neurologic symptoms of pain and paraesthesiaeoccur independently of the attacks of vasospasm (Bremmer andTaylor, 1982). Hand–arm vibration syndrome/vibration white
finger (VWF)1 has been recognized as an occupational disease since
early this century (Hamilton, 1918), but the pathophysiology of the
disease is poorly understood. In the United Kingdom, VWF has been
a financially compensatable industrial disorder (i.e., a ‘‘prescribed’’
disease) since the mid-1980s (Social Security, 1985). At present there
is no objective diagnostic test and claims are awarded on clinical
grounds alone.
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vibration-exposed workers had significantly lower resting
skin blood flow at both 21°C and 4°C than heavy manual
workers with no vibration exposure. The size of the
histamine- and ET-1-induced flares at both 21°C and 4°C
was significantly smaller in patients with VWF when
compared with the asymptomatic vibration-exposed
workers and heavy manual workers. The size of the
ET-1-induced pallor was smaller in patients with VWF
when compared with the heavy manual workers at both
21°C and 4°C. In contrast, the area of erythema induced
by intradermal injection of calcitonin gene-related pep-
tide at both 21°C and 4°C was of a similar size in patients
with VWF and in heavy manual workers. These results
indicate that the neuroneal deficit identified by immuno-
histochemistry in the digital skin of patients with VWF
has a functional counterpart in vivo and is evident as a
reduced ability to propagate an axon-reflex vasodilator
response when challenged with histamine and ET-1.
Furthermore, these results enable patients with VWF to
be differentiated from both asymptomatic vibration-
exposed workers, in whom the histamine- and ET-1-
induced flares are normal, and those with primary
Raynaud’s disease, in whom the ET-1 flare is reduced
and the histamine-induced flare is normal. Key word: skin
blood flow. J Invest Dermatol 110:127–131, 1998
We have previously reported that patients with VWF have a
significant reduction in the number of sensory-motor nerves containing
the vasodilator calcitonin gene-related peptide (CGRP) and also a
reduction in the number of protein gene product 9.5 (PGP 9.5)
immunopositive nerve fibers in their digital skin (Goldsmith et al,
1994). The reduction in the number of PGP 9.5 immunopositive
nerve fibers is greater than can be accounted for solely by the reduction
in the number of CGRP immunopositive nerve fibers, indicating that
these individuals have a more widespread neuroneal loss than has been
described in patients with either primary Raynaud’s phenomenon or
Raynaud’s phenomenon secondary to connective tissue disease
(Terenghi et al, 1991; Dowd et al, 1995).
Axon-reflex vasodilatation is an important mechanism in the local
1Two terms are recommended in a recent report written by a working party
of the Faculty of Occupational Medicine at the Royal College of Physicians
(United Kingdom). They are ‘‘hand-arm vibration syndrome’’ and ‘‘vibration-
induced white finger.’’ We have opted to use the term vibration white finger,
first because all the subjects used in the studies suffer with episodes of blanching
in the fingers and second because the term is commonly adopted and universally
understood.
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control of blood flow in skin and in cutaneous responses to changes
in environmental temperature. It has been recognized for many
years that sensory neuronal degeneration attenuates peripheral vascular
responses (Bruce, 1913). Capsaicin-sensitive unmyelinated ‘‘C’’ fibers
and thinly myelinated ‘‘Aδ’’ fibers are involved in axon-reflex vasodilat-
ation (Jancso et al, 1967; Lynn, 1988; Janig and Lisney, 1989) and a
proportion of these nerves contain CGRP (Dalsgaard et al, 1989;
Lawson, 1992). Sensory-motor fibers form a network of branches: one
branch is associated with polymodal nociceptors and the other branch
forms a neuro-effector junction with target cells such as blood vessels
and mast cells (Celander and Folkow, 1953). A decrease in the number
of functionally active sensory-motor fibers and the degree of branching
may contribute significantly to the reduced ability to mount a vasodilator
response in the face of increasing vasoconstriction in situations such as
cold or emotional provocation, or trauma induced by physical agents
such as vibration.
Axon-reflex vasodilatation can be assessed in vivo using intradermal
injection compounds such as endothelin-1 (ET-1) and histamine and
measuring the area of the flare generated. Intradermal injection of
histamine induces a classic wheal and flare response; the ‘‘triple
response’’ of Sir Thomas Lewis (Lewis, 1927). The flare response is
maximal within 2 min of injection and is inhibited by pretreatment of
the skin with capsaicin (Bernstein et al, 1981) or by local anesthetic
(Lewis, 1927). We have already established that the response to
histamine in patients with primary Raynaud’s phenomenon is similar
to that in age- and sex-matched controls at both 21°C and 4°C
(Bunker et al, 1991a, b).
When injected intradermally into normal skin ET-1 produces an
intense vasoconstrictor response that is evident as an area of pallor in
the immediate vicinity of the injection site. ET-1 also induces a flare
that spreads for several square centimetres around the area of pallor
(Bunker et al, 1992). This flare is blocked by pretreatment of the skin
with capsaicin and by local anesthetic (Bunker et al, 1992), indicating
that it too is neurogenic. In patients with primary Raynaud’s phenome-
non, the ET-1-induced flare is reduced at 21°C and more markedly
so at 4°C. In contrast the ET-1-induced pallor is not significantly
different in patients with primary Raynaud’s phenomenon (Bunker
et al, 1996).
CGRP is a potent vasodilator and intradermal injection into human
skin produces an intense and long-lasting erythema (Piotrowski and
Foreman, 1986). The CGRP-induced erythema is not neurogenically
mediated because neither local anesthetic nor capsaicin pretreatment
block the vasodilator response. Instead, CGRP acts directly on the
blood vessels of the cutaneous microvasculature to induce vasodilatation
partly by stimulating release of nitric oxide from the endothelium
(Goldsmith et al, 1996; Bull et al, 1996).
In this study, we have sought to determine whether the neuronal
deficit that has been identified by immunohistochemistry in the digital
skin of patients with VWF has a functional counterpart in vivo. Resting
skin blood flow has been measured in each of the digits and the axon-
reflex vasodilator responses to intradermal injections of ET-1 and
histamine have been compared in patients with VWF, in vibration-
exposed workers (VEW) who have been exposed to vibration for a
similar length of time but have no neurologic or vascular symptoms,
and in heavy manual workers (HMW) who have not worked with
vibrating tools. The ability of the blood vessels to vasoconstrict and
vasodilate in response to direct stimulation has been investigated by
measuring the area of the ET-1-induced pallor and the CGRP-induced
erythema, respectively.
MATERIALS AND METHODS
Subjects Local Ethical Committee approval was obtained for this study.
Twenty-one men with VWF, 20 VEW, and 13 HMW were recruited for this
study (Table I) and all gave written, informed consent. All subjects were
nonsmokers.
VWF was diagnosed if the patients had episodes of digital ischemia occurring
in response to cold or emotional stimuli and characteristic sequential color
changes (white, blue, red) in the affected parts. In addition, the patients had to
have experienced pain and/or paresthesia in their fingers and hands that occurred
independently from the vasospastic episodes. All patients had to have worked
Table I. Details of groups investigated
Parameter VWF VEW HMW
Number 21 20 13
Mean age (y) 42.6 43.3 41.7
Range (y) 25–64 27–61 26–62
Mean vibration exposure (y) 21 19 –
Range (y) 9–41 5–34 –
with hand-held vibrating machinery of the type that is recognized to cause the
disease (Social Security, 1985), but not to have had any symptoms of peripheral
vasospastic disease or neurologic symptoms prior to exposure to hand-held
vibrating tools. The patients had to have negative appropriate screening
investigations for associated diseases such as systemic sclerosis, systemic lupus
erythematosus, and rheumatoid arthritis according to the criteria of the
Subcommittee for Scleroderma Criteria of the American Rheumatism Associ-
ation Diagnostic and Therapeutic Criteria Committee (1980) and had not to
be taking any drugs. The patients were assessed as to the severity of their
vascular and neurologic symptoms and signs and were staged clinically according
to the Stockholm (Gemne et al, 1987) and Griffin scales (Griffin, 1990).
Experimental protocol All subjects were initially equilibrated in the labora-
tory at an ambient temperature of 21°C. Resting skin blood flow was measured
in each digit using a laser Doppler flowmeter (Perimed, Stockholm, Sweden).
Intradermal injections of 25 µl containing 750 pmol histamine (Sigma, Poole,
U.K.) and 63 pmol human synthetic ET-1 (Novabiochem, Nottingham, U.K.)
were made into the dorsal digital skin over the middle phalanx of one hand.
The injections were made randomly and the investigators were unaware of the
contents of each syringe. After completion of the experiments at 21°C, the
patients with VWF and the HMW, wearing normal outdoor clothing, were
introduced into an environmental chamber set at 4–5°C and the experiments
repeated on the fingers of the contralateral hand. HMW and nine patients with
VWF also received an intradermal injection of 25 µl containing 12.5 pmol
human synthetic CGRP (Peninsula Labs, St Helens, U.K.) at both 21°C and
4°C. All of the agonists were prepared in endotoxin-free sterile saline.
The neurovascular responses were measured by planimetry as previously
described (Bunker et al, 1991a). The erythema, flare, and pallor size were
measured along the longitudinal axis of the finger in millimetres and at a right
angle to the longitudinal axis and the area calculated. Measurements were made
at 2 and 10 min after injection of ET-1 and histamine and at 10 and 20 min
after injection of CGRP.
Statistical analysis Experimental results are expressed as the mean 6 SEM.
Differences between the groups were analyzed using either the Mann–Whitney
U test or the unpaired Student’s t test (two group analysis) or analysis of
variance with the confidence limits set at 95% (three group analysis). A p ø 0.05
was considered to be statistically significant.
Regression analysis was used to compare the size of the ET-1 and histamine
flares, the CGRP-induced erythema, and the ET-1-induced pallor with the
clinical scores obtained using the Stockholm and Griffin scales.
RESULTS
Long-term vibration exposure reduces resting digital skin blood
flow The resting digital skin blood flow was significantly reduced
(p , 0.05) in patients with VWF and in asymptomatic VEW at both
21°C (Fig 1a) and 4°C (Fig 1b), in comparison with HMW. In each
group, there was no significant difference in the resting digital skin
blood flow at 4°C compared with that at 21°C.
The size of the histamine-induced flare is reduced in patients
with VWF At 21°C (Fig 2a), the size of the histamine-induced
flare in the patients with VWF was significantly smaller (p , 0.05) at
2 min after injection, when compared with either the VEW or HMW,
but was only significantly smaller (p , 0.05) at 10 min post-injection
when compared with the VEW. Similarly, at 4°C (Fig 2b) the
histamine-induced flare in patients with VWF was significantly smaller
(p , 0.05) at 2 min but not at 10 min after injection, when compared
with the HMW.
The size of the ET-1-induced flare is reduced in patients with
VWF Intradermal injection of ET-1 induced a flare response that
surrounded the central area of pallor. At 21°C (Fig 3a), the size of
the ET-1-induced flare in patients with VWF was significantly smaller
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Figure 1. Long-term vibration exposure reduces resting digital skin
blood flow. Resting digital skin blood flow in patients with VWF (n 5 20),
in VEW (n 5 19), and in HMW (n 5 13) at (a) 21°C and (b) 4°C. The results
are expressed as the mean 1 SEM; *p , 0.05 relative to HMW. LDF, laser
Doppler flowmetry.
Figure 2. The histamine-induced flare is reduced in VWF. The area of
the histamine-induced flare in patients with VWF (n 5 20), in VEW (n 5
19), and in HMW (n 5 13) was measured at 2 min and 10 min after injection
at (a) 21°C and (b) 4°C. The results are expressed as the mean 1 SEM;
*p , 0.05 relative to VEW and HMW; dp , 0.05 relative to VEW alone.
(p , 0.05) at 2 min after injection when compared with the
asymptomatic VEW and at 10 min after injection when compared
with either the VEW or the HMW. At 4°C (Fig 3b) the size of the
ET-1-induced flare was significantly smaller (p , 0.05) in patients
with VWF than in the HMW at both 2 min and 10 min after injection.
Furthermore, there was a significant increase (p , 0.05) in the size of
the ET-1-induced flare between 2 and 10 min in the HMW at 21°C
Figure 3. The ET-1-induced flare is reduced in VWF. The area of the
ET-1-induced flare in patients with VWF (n 5 20), in VEW (n 5 19), and in
HMW (n 5 13) was measured at 2 min and 10 min after injection at (a) 21°C
and (b) 4°C. The results are expressed as the mean 1 SEM; *p , 0.05 relative
to VEW and HMW; dp , 0.05 relative to VEW alone; d dp , 0.05 relative
to 2 min.
and 4°C that was not evident in either the VEW at 21°C or the
patients with VWF at either 21°C or 4°C.
The size of the ET-1-induced pallor is increased in patients
with VWF Intradermal injection of ET-1 induced an area of pallor
immediately around the injection site. In all groups at 21°C (Fig 4a)
and 4°C (Fig 4b) the area of pallor was larger at 10 min than at 2 min
after injection. This increase in size was statistically significant (p , 0.05)
in the HMW at 21°C and 4°C and in the patients with VWF at 4°C.
At 2 min after injection the size of the ET-1-induced pallor at both
21°C (Fig 5a) and 4°C (Fig 5b) was significantly larger (p , 0.05) in
patients with VWF in comparison with the HMW.
The size of the CGRP-induced erythema is unchanged in
patients with VWF Intradermal injection of CGRP induced an
area of erythema around the injection site. At 21°C (Fig 5a) and 4°C
(Fig 5b), the area of erythema in patients with VWF was not
significantly different from that observed in the HMW.
Flare size does not correlate with clinical scores There was no
correlation between size of the flare produced by ET-1 or histamine, the
CGRP-induced erythema, or the ET-1-induced pallor and individual
clinical scores obtained using either the Stockholm classification of the
sensorneural and vascular components of VWF or the Griffin scoring
system of the vascular symptoms (data not shown).
DISCUSSION
The results of this study have demonstrated that patients with VWF
have a reduced ability to propagate an axon-reflex vasodilatation
response when challenged with either histamine or ET-1, indicating
that the neuronal deficit identified by immunohistochemical studies in
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Figure 4. The ET-1-induced pallor is increased in VWF. The area of the
ET-1-induced pallor in patients with VWF (n 5 20), in VEW (n 5 19), and
in HMW (n 5 13) was measured at 2 min and 10 min after injection at (a)
21°C and (b) 4°C. The results are expressed as the mean 6 SEM; *p , 0.05
relative to HMW; d dp , 0.05 relative to 2 min.
Figure 5. The CGRP-induced erythema is unchanged in VWF. The area
of the CGRP-induced erythema in patients with VWF (n 5 9) and in HMW
(n 5 9) was measured at 10 min and 20 min after injection at (a) 21°C and
(b) 4°C. The results are expressed as the mean 6 SEM.
these patients (Goldsmith et al, 1994) has a functional counterpart
in vivo. The reduction in the size of the flare generated in response to
both ET-1 and histamine distinguishes patients with VWF from both
asymptomatic VEW, in whom the ET-1- and histamine-induced
flare responses are normal, and individuals with primary Raynaud’s
phenomenon, in whom the size of the ET-1-induced flare alone is
reduced (Bunker et al, 1996). The results of this study are also in
keeping with the more extensive neuronal loss identified in patients
with VWF (Goldsmith et al, 1994) compared with that identified in
patients with primary Raynaud’s phenomenon (Bunker et al, 1990;
Terenghi et al, 1991).
Patients with VWF and also VEW exhibited significantly lower
resting skin blood flow than the HMW as measured by laser Doppler
flowmetry. Lower resting skin blood flow has previously been demon-
strated in Raynaud’s phenomenon (Bunker et al, 1996, and refs therein);
however, in patients with VWF the data have been contradictory with
decreased (Olsen et al, 1989) and unchanged resting skin blood flow
(Allen et al, 1992) being reported. Olsen et al (1989) also reported
normal resting skin blood flow in asymptomatic VEW. Acute vibration
of individual digits decreases blood flow in vibration-exposed digits in
normal individuals and in both the vibration-exposed and adjacent
nonexposed digits in patients with VWF (Kent et al, 1991), indicating
that acute exposure to vibration induces local vasoconstriction whereas
long-term exposure to vibration results in increased centrally mediated
vasoconstrictor tone. The results of this study have shown that the
resting digital skin blood flow is reduced in asymptomatic VEW,
suggesting that these individuals have incurred subclinical neuronal
damage that has selectively affected the centrally mediated sympathetic
tone without impairing their ability to mount a local axon-reflex
vasodilator response. This, in turn, may explain why these workers do
not suffer from attacks of digital vasospasm.
Hand-transmitted vibration does not impair the ability of the
cutaneous microvasculature to respond to vasoactive stimuli because
the size of neither the CGRP-induced erythema nor the ET-1-induced
pallor are reduced. The erythema generated in response to intradermal
injection of CGRP is of a similar size in patients with VWF and
HMW. Furthermore, the size of the ET-1-induced pallor is significantly
larger in patients with VWF than in HMW at 2 min after injection
and of comparable size 10 min after injection. The rapid onset of the
vasoconstrictor response to ET-1 is a reflection of the damage to the
sensory-motor neuroneal network and the reduced ability to generate
an axon-reflex vasodilatation response.
The lack of correlation between the size of the ET-1- and histamine-
induced flares and the clinical score is not unexpected. The clinical
scores are based on subjective assessment of the area prone to be
affected by vibration-induced damage. In contrast, the size of the flare
is an objective indicator of sensory-motor neuroneal function at a
particular anatomical site.
VWF is an occupationally induced disease for which there is currently
no objective test. The results of the in vivo pharmacologic studies
presented here and the immunohistochemical analysis presented previ-
ously (Goldsmith et al, 1994) enable patients with VWF to be
differentiated from asymptomatic VEW. In vivo pharmacologic testing
either alone or in combination with the immunohistochemical analysis
of the peripheral innervation may therefore provide the basis for a
objective diagnostic test for VWF.
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